Amgen and Xencor, Inc. announced today that the two companies have entered into a research and license agreement to develop and commercialize novel therapeutics in the areas of cancer immunotherapy and inflammation.
More...
Medical.net - Amgen, Xencor partner to develop and commercialize new therapeutics for
More...
0 commentaires:
Enregistrer un commentaire